access to treatment
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
access to treatment
May 31, 2024, 07:25 |
Blog
The European Week Against Cancer: Day 1 Theme is Primary Prevention - SIOP Europe
SIOP Europe shared on LinkedIn: . "The European Week Against Cancer starts today! Did you…
May 31, 2024, 03:27 |
Blog
CML Horizons was an impressive gathering of global leaders exploring the latest in Chronic Myeloid Leukemia advocacy and care! - The Max Foundation
The Max Foundation shared on LinkedIn: “Last week's CML Horizons was an impressive gathering of global…
May 22, 2024, 11:43 |
Blog
Riccardo Moschetti: Back in Bratislava after one year to present progress in cancer prevention
Riccardo Moschetti, Policy Officer at European Cancer Organisation, shared a post by European Cancer Organisation…
Feb 23, 2024, 14:31 |
Blog
Rasika Bombatkar: The rejection of my application for adjuvant Osimertinib is disheartening to say the least
Rasika Bombatkar, Citizen Scientist at LUNGevity Foundation, cancer patient and advocate, shared on X: "AstraZeneca,…
Dec 10, 2023, 16:59 |
Insight
Yüksel Ürün: MFS continues to be a reliable predictor for overall survival
Yüksel Ürün, Medical Oncologist at Ankara University, shared on X: “With better access to docetaxel…
Nov 29, 2023, 17:00 |
Insight
Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
Maite Bourlon, Urology Oncologist at the National Institute of Medical Sciences and Nutrition Salvador Zubirán,…
All:
6
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube